BigRed - Nothing can be more far from the truth mate. I am invested in 3 late stage Biotechs in USA. BioCryst Pharmaceuticals, BioTime, Inc and CEL-SCI Corp. Been invested in them for a little over 2.5 years. In this period - NOT a single deadline has been met to the date .. or even the month. There are ALWAYS delays and at times far greater than anticipated.
We need to compare apples to apples. Lets not talk about a J&J or a GSK who have twice more people in their regulatory department than all of the employees of TIS.
Resourced - I was hoping to hear a few good words from you when One of the Best Rated Universities in Australia had a subtle TIS advert on their home page right up the top. Yet nothing! As an investor, if all you are concerned with is finding flaws, then little more can be said.
My Take - So far the management has delivered on expectations. The ones who were dissatisfied (like the national ethical mob) are now 30% lower than where they could have been.
The only way to make money in investing is to think the way the large investors think. While some of us have been cribbing and complaining - there has been a huge accumulation going on The price action, trading style and Volumes are pretty clear indications of that fact.
I love a nice argument - but one can only argue on facts, fundamentals and direction as long as they have the same timeline in perspective. For a day trader or a short term trader, anything I say will make no sense and vice-versa.
My 2c - No advice given or intended.
TIS Price at posting:
47.0¢ Sentiment: Buy Disclosure: Held